会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Nucleic acid molecule capable of binding to c-Met and use thereof
    • 能够结合c-Met的核酸分子及其用途
    • US08822667B2
    • 2014-09-02
    • US13812190
    • 2011-07-26
    • Naomi HirabayashiShotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • Naomi HirabayashiShotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • C07H21/04C07H21/02A61K48/00
    • C07H21/02A61K31/52A61K31/7105C12N15/115C12N2310/16C12Q1/6883C12Q2525/301C12Q2527/125A61K2300/00
    • The present invention provides a nucleic acid molecule capable of binding to c-Met as a substance that can be used for clarification of the pathogenic mechanism of diseases caused by c-Met, diagnosis and treatment of the diseases, and the like, and also the use thereof. The c-Met binding nucleic acid molecule of the present invention is any one of the following nucleic acid molecules (A1), (A2), (B1), and (B2). (A1) a nucleic acid molecule including the base sequence of any one of SEQ ID NOs: 1 to 38 (A2) a nucleic acid molecule that is capable of binding to c-Met and includes a base sequence obtained by substitution, deletion, addition, and/or insertion of one or more bases in the base sequence of any one of SEQ ID NOs: 1 to 38 (B1) a nucleic acid molecule including the base sequence of any one of SEQ ID NOs: 39 to 76 (B2) a nucleic acid molecule that is capable of binding to c-Met and includes a base sequence obtained by substitution, deletion, addition, and/or insertion of one or more bases in the base sequence of any one of SEQ ID NOs: 39 to 76.
    • 本发明提供能够结合c-Met的核酸分子,作为能够用于澄清由c-Met,疾病的诊断和治疗等引起的疾病的致病机制的物质,以及 使用它。 本发明的c-Met结合核酸分子是以下核酸分子(A1),(A2),(B1)和(B2)中的任一种。 (A1)包含SEQ ID NO:1至38(A2)中任一个的碱基序列的核酸分子,其能够结合c-Met并包含通过取代,缺失,加成获得的碱基序列 ,(SEQ ID NO:39)至(38)中的任何一个的碱基序列的核酸分子,和/或在SEQ ID NO:1至38(B1)中任一个的碱基序列中插入一个或多个碱基, 能够结合c-Met的核酸分子,并且包含通过SEQ ID NO:39至76中任一个的碱基序列中的一个或多个碱基的取代,缺失,添加和/或插入获得的碱基序列 。
    • 7. 发明申请
    • NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-MET AND USE THEREOF
    • 可以与C-MET结合的核酸分子和其使用
    • US20130123350A1
    • 2013-05-16
    • US13812190
    • 2011-07-26
    • Naomi HirabayashiShotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • Naomi HirabayashiShotaro TsujiJou AkitomiShintarou KatouIwao WagaTakashi Ohtsu
    • C07H21/02
    • C07H21/02A61K31/52A61K31/7105C12N15/115C12N2310/16C12Q1/6883C12Q2525/301C12Q2527/125A61K2300/00
    • The present invention provides a nucleic acid molecule capable of binding to c-Met as a substance that can be used for clarification of the pathogenic mechanism of diseases caused by c-Met, diagnosis and treatment of the diseases, and the like, and also the use thereof. The c-Met binding nucleic acid molecule of the present invention is any one of the following nucleic acid molecules (A1), (A2), (B1), and (B2).(A1) a nucleic acid molecule including the base sequence of any one of SEQ ID NOs: 1 to 38 (A2) a nucleic acid molecule that is capable of binding to c-Met and includes a base sequence obtained by substitution, deletion, addition, and/or insertion of one or more bases in the base sequence of any one of SEQ ID NOs: 1 to 38 (B1) a nucleic acid molecule including the base sequence of any one of SEQ ID NOs: 39 to 76 (B2) a nucleic acid molecule that is capable of binding to c-Met and includes a base sequence obtained by substitution, deletion, addition, and/or insertion of one or more bases in the base sequence of any one of SEQ ID NOs: 39 to 76
    • 本发明提供能够结合c-Met的核酸分子,作为能够用于澄清由c-Met,疾病的诊断和治疗等引起的疾病的致病机制的物质,以及 使用它。 本发明的c-Met结合核酸分子是以下核酸分子(A1),(A2),(B1)和(B2)中的任一种。 (A1)包含SEQ ID NO:1至38(A2)中任一个的碱基序列的核酸分子,其能够结合c-Met并包含通过取代,缺失,加成获得的碱基序列 ,(SEQ ID NO:39)至(38)中的任何一个的碱基序列的核酸分子,和/或在SEQ ID NO:1至38(B1)中任一个的碱基序列中插入一个或多个碱基, 能够结合c-Met的核酸分子,并且包含通过SEQ ID NO:39至76中任一个的碱基序列中的一个或多个碱基的取代,缺失,添加和/或插入获得的碱基序列
    • 10. 发明申请
    • APPLICATION OF FLUORESCENT PROTEIN TO GARDEN PLANT
    • 荧光蛋白应用于园艺植物
    • US20100043104A1
    • 2010-02-18
    • US12374995
    • 2007-07-25
    • Iwao WagaHiromi TakenakaShu Muto
    • Iwao WagaHiromi TakenakaShu Muto
    • C12N15/82
    • C12N15/8212C07K14/43509
    • The present invention provides a process for generation of a transformed plant capable of emitting fluorescence by introducing a gene encoding a non-plant-derived fluorescent protein into a plant such that the fluorescent protein is recombinantly expressed in the active form of its mature protein in the leaf or petal of the plant, and also provides a transformed garden plant capable of emitting fluorescence that is generated by using the process. For example, cDNA encoding the full-length amino acid sequence of a Chiridius poppei-derived fluorescent protein CpYGFP or its H52F modified protein CpYGFP H52F is inserted into a T-DNA-based expression vector system, which is in turn introduced into the chromosomal DNA of a plant. As a result, the transformed plant thus generated can exhibit fluorescence attributed to these fluorescent proteins and exhibit no substantial difference in the other phenotypes from wild-type one of the plant.
    • 本发明提供一种通过将编码非植物来源的荧光蛋白的基因导入植物而产生能够发射荧光的转化植物的方法,使得荧光蛋白以其成熟蛋白的活性形式重组表达 植物的叶或花瓣,并且还提供能够发射通过使用该过程产生的荧光的转化的花园植物。 例如,将编码Chiridius Poppei衍生的荧光蛋白CpYGFP或其H52F修饰的蛋白质CpYGFP H52F的全长氨基酸序列的cDNA插入到基于T-DNA的表达载体系统中,其进而导入染色体DNA 的植物。 结果,由此产生的转化植物可以表现出归因于这些荧光蛋白的荧光,并且在野生型植物中的其它表型中没有显示实质性差异。